EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices Dec 17, 2021 12:45PM
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III (CMLTU) Aug 6, 2021 07:14AM
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III Aug 6, 2021 07:00AM
CM Life Sciences III Inc. Announces Separate Trading of Its Shares of Class A Common Stock and Warrants, on or About May 28, 2021 May 26, 2021 04:15PM
CM Life Sciences III Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Closing of $552 Million Initial Public Offering Apr 9, 2021 04:20PM


Apr 7, 2021 10:27AM IPO for SPAC CM Life Sciences III (CMLT) Opens at $11
Apr 7, 2021 06:04AM CM Life Sciences III (CMLT) SPAC Prices 48M Shares Upsized Offering at $10
Apr 6, 2021 10:10PM CM Life Sciences III Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $480 Million Initial Public Offering